Abstracts tagged "fibromyalgia"

Abstract Number: 225 • 2019 ACR/ARP Annual Meeting
Evaluating Fibromyalgia Symptoms in Transgender Patients
Dana Levit¹, Jacob Ablin ¹, Valerie Aloush ¹ and Iris Yaish ¹, ¹Tel Aviv Sourasky medical center, Tel Aviv, Israel
Background/Purpose: Fibromyalgia Syndrome (FMS), characterized by widespread pain and fatigue, is known to be more prevalent in women, and has frequently been associated with stress…
Abstract Number: 830 • 2019 ACR/ARP Annual Meeting
The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis
Burak Kundakci¹, Jaspreet Kaur ², Siew-Li Goh ³, Michelle Hall ⁴, Michael Doherty ⁵, Weiya Zhang ⁵ and Abhishek Abhishek ⁶, ¹Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK, Nottingham, United Kingdom, ²Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK, Nottingham, United Kingdom, ³Sports Medicine Unit, University of Malaya, Kuala Lumpur, Malaysia, Kuala Lumpur, Malaysia, ⁴Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK/Division of Physiotherapy and Rehabilitation Sciences, University of Nottingham, Nottingham, UK, Nottingham, United Kingdom, ⁵Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/Arthritis Research UK Pain Centre, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK, Nottingham, United Kingdom, ⁶Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK/National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK, Nottingham, United Kingdom
Background/Purpose: Non-pharmacological interventions are recommended as first-line treatment for fibromyalgia (FM)1. However, the evidence base supporting this has not been updated comprehensively, and the recent…
Abstract Number: 226 • 2019 ACR/ARP Annual Meeting
Hypersensitivity Beyond Pain: Hyperacusis and Hyperalgesia of Patients with Fibromyalgia
Roland Staud ¹, Gabriella Tom¹, Melyssa Godfrey ¹ and Michael Robinson ¹, ¹University of Florida, Gainesville, FL
Background/Purpose: Fibromyalgia (FM) is a condition in which patients are afflicted with unexplained chronic musculoskeletal pain, insomnia and fatigue. The underlying mechanisms of this disorder…
Abstract Number: 831 • 2019 ACR/ARP Annual Meeting
Maintaining Musculoskeletal Health: A Randomized Controlled Prevention Trial Amongst People at High Risk of Developing Chronic Widespread Pain
Gary Macfarlane¹, Marcus Beasley ¹, Neil Scott ¹, Gordon Prescott ², Paul McNamee ¹, John McBeth ³, Gareth Jones ¹, Neil Basu ⁴, Phil Hannaford ¹, Phil Keeley ⁵ and Karina Lovell ⁶, ¹University of Aberdeen, Aberdeen, United Kingdom, ²University of Central Lancashire, Preston, United Kingdom, ³Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, ⁴University of Glasgow, Glasgow, United Kingdom, ⁵University of Huddersfield, Huddersfield, United Kingdom, ⁶University of Manchester, Manchester, United Kingdom
Background/Purpose: Cognitive behaviour therapy (CBT) is effective in the management of fibromyalgia (and its characteristic feature Chronic Widespread Pain (CWP). CBT is recommended in all…
Abstract Number: 227 • 2019 ACR/ARP Annual Meeting
Metabolomic and Symptom Comparison in Women With/without Fibromyalgia: A Pilot Study
Victoria Menzies¹, Angela Starkweather ², Yingwei Yao ³, Timothy Garrett ⁴, Debra Lynch-Kelly ³, Param Patel ² and Debra E. Lyon ³, ¹Virginia Commonwealth University School of Nursing, Richmond, VA, ²University of Connecticut School of Nursing, Storrs, CT, ³College of Nursing, University of Florida, Gainesville, FL, ⁴Southeast Center for Integrated Metabolomics, University of Florida, Gainesville, FL
Background/Purpose: The biological perturbations associated with fibromyalgia (FM) remain unclear. The recognition of objective measures to confirm FM diagnosis have not been identified. The obscurity…
Abstract Number: 1195 • 2019 ACR/ARP Annual Meeting
Quantitative Physician Global Assessment of Damage And/or Distress, in Addition to Inflammation, at Routine Rheumatology Care: Documenting the Complexity of Rheumatology Patient Encounters as a Rationale for Possible Higher Reimbursement?
Theodore Pincus¹, Isabel Castrejon ² and Joel A. Block ², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Quantitative clinical measures and indices such as DAS28, CDAI, SLEDAI, BASDAI, are designed to assess inflammation, reflecting a goal to prevent long-term damage, and…
Abstract Number: 228 • 2019 ACR/ARP Annual Meeting
Good Pain, Bad Pain: Illness Perception and Physicians Attitude Towards Rheumatoid Arthritis and Fibromyalgia Patients
Valerie Aloush¹, Dana Niv ², Jacob Ablin ³, Iris Yaish ³, Ori Elkayam ³ and Odelia Elkana ², ¹Tel Aviv Sourasky medical center, Tel Aviv, ²Academic College Tel Aviv- Yaffo, Tel Aviv, Israel, ³Tel Aviv Sourasky medical center, Tel Aviv, Israel
Background/Purpose: Rheumatoid arthritis and fibromyalgia are common diagnoses encountered in rheumatology practice. While rheumatoid arthritis is perceived as a valid medical condition and patients receive…
Abstract Number: 2076 • 2019 ACR/ARP Annual Meeting
The Opioid Epidemic: The Rheumatology Response to Management of Chronic Pain
Michael Grant¹, Alysia Kwiatkowski ¹ and Najia Shakoor ¹, ¹Rush University Medical Center, Chicago, IL
Background/Purpose: Pain is the hallmark symptom of many rheumatologic conditions and chronic pain management is a major part of clinical practice in rheumatology. Therefore, as…
Abstract Number: 231 • 2019 ACR/ARP Annual Meeting
Duloxetine for Chronic Pain Management in a Tertiary Care Rheumatology Practice: How Patients Are Doing in the Real World
Rupal Shastri¹, Sonali Khandelwal ² and Najia Shakoor ², ¹Rush University, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Chronic pain is a complicated issue that has received a significant amount of attention. In particular, studies suggesting the role of central sensitization in…
Abstract Number: 2267 • 2019 ACR/ARP Annual Meeting
The Association Between Non-restorative Sleep and Diurnal Patterns of Cognitive Function and Fatigue in People with Fibromyalgia and Matched Controls
Daniel Whibley¹, David Williams ², Daniel Clauw ³ and Anna Kratz ⁴, ¹University of Aberdeen; University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, ³Division of Rheumatology, Department of Internal Medicine and Division of Anesthesia, Michigan Medicine, Ann Arbor, MI, ⁴University of Michigan, Ann Arbor, MI
Background/Purpose: Non-restorative sleep is associated with poorer cognitive function and greater fatigue, not only in people living with fibromyalgia (FM), but also in the general…
Abstract Number: 232 • 2019 ACR/ARP Annual Meeting
Hand Digital Thermography Findings in Patients with Primary Fibromyalgia
Diego Felipe Garcia¹, David Herrera-Van Oostdam ¹, Ricardo moreno Valdés ², Eva Santillan Guerrero ² and Carlos Abud-Mendoza ³, ¹Hospital Central “Dr Ignacio Morones Prieto”, Unidad Regional de Reumatologia y Osteoporosis, Hospital Central and Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, san luis potosi, San Luis Potosi, Mexico, ²Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico, ³Hospital Central “Dr Ignacio Morones Prieto”, Unidad Regional de Reumatologia y Osteoporosis, Hospital Central and Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosi, Mexico
Background/Purpose: Fibromyalgia is a diffuse chronic painful disease, with prevalence of 0.5% -12%, with a female:male ratio 3:10. Because of unexplained symptoms, particularly as disability…
Abstract Number: 2472 • 2019 ACR/ARP Annual Meeting
The Role of Ultrasound for the Assessment of Psoriatic Arthritis Patients with Fibromyalgia – Interim Analysis
Ari Polachek¹, Victoria Furer ², Mirna Zureik ², Sharon Nevo ², Liran Mendel ², David Levartovsky ³, Jonathan Wollman ⁴, Valerie Aloush ⁵, Mark Berman ⁶, Ilana Kaufman ⁶, Yael Lahat ², Hagit Sarbagil-Maman ⁷, Sara Borok ⁶, Adi Broyde ⁶, Lihi Eder ⁸, Daphna Paran ¹ and Ori Elkayam ⁹, ¹Tel-Aviv Sourasky medical center, Tel Aviv, Israel, ²Sourasky Medical Center, Tel-Aviv, Israel, ³Sourasky medical center, Tel Aviv, Israel, ⁴Sourasky Medical Center, Herzelia, Israel, ⁵Tel Aviv Sourasky medical center, Tel Aviv, ⁶Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ⁷Tel-Aviv Sourasky medical center, Qiryat-Ono, Israel, ⁸Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada, ⁹Rheumatology Department, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel., Tel Aviv, Israel
Background/Purpose: Psoriatic arthritis is a chronic inflammatory disease. More than 20% of patients with PsA patients suffer from fibromyalgia, a chronic pain syndrome characterized by…
Abstract Number: 233 • 2019 ACR/ARP Annual Meeting
Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms?
Barbara Bruce ¹, Madeleine Allman ², Jessica Gehin¹, Loretta Oliphant ¹, Fernando Rivera ¹ and Andy Abril ¹, ¹Mayo Clinic, Jacksonville, FL, ²Baylor College of Medicine, Houston, TX
Background/Purpose: The study was designed to evaluate the effectiveness and durability of an intensive cognitive behavioral intervention on functioning and depression in patients with Fibromyalgia…
Abstract Number: 2721 • 2019 ACR/ARP Annual Meeting
Subjective and Objective Dyscognition in Adolescents with Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Maitry Sonagra ², Rui Xiao ², Elizabeth Mendoza ², Kimberly S. Miller ³, Nina H. Thomas ¹, Pamela F. Weiss ¹, David D. Sherry ¹ and Jeffrey Gerber ², ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, ³Children's Hospital fo Philadelphia, Philadelphia, PA
Background/Purpose: Dyscognition, including loss of mental clarity and problems with attention and memory, often affects adolescents with juvenile fibromyalgia syndrome (JFMS). Our understanding of this…
Abstract Number: 237 • 2019 ACR/ARP Annual Meeting
Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results
Alexandra Katz Small¹, Ben Small ², Jessica Polyak Wokurka ² and Robert Katz ³, ¹Rush University Medical Center, Chicago, ²Rheumatology Associates, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: Muscle pressure is increased in fibromyalgia as measured by a pressure gauge with a needle inserted into the trapezius muscle. We attempted to evaluate…

« Previous Page
1
…
8
9
10
11
12
…
23
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].